---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-044124"
form_type: "8-K"
ticker: "LTRN"
cik: "0001763950"
company_name: "Lantern Pharma Inc."
filed_at: "2024-11-08T23:59:59+00:00"
generated_at: "2026-05-30T02:55:08.652863+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Lantern Pharma Q3 2024 earnings call held; no financial details in 8-K

## Summary
- Conference call and live webinar occurred on November 7, 2024 for Q3 results.
- Presentation covering financial and operating results furnished as Exhibit 99.1.
- No specific revenue, EPS, or guidance figures were disclosed in this filing.

## SEC filing metadata
- accession: 0001493152-24-044124
- form_type: 8-K
- ticker: LTRN
- cik: 0001763950
- company_name: Lantern Pharma Inc.
- filed_at: 2024-11-08T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1763950/000149315224044124/0001493152-24-044124-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1763950/000149315224044124/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-044124
- JSON: https://secwatch.observer/filing/0001493152-24-044124.json
- Plain text: https://secwatch.observer/filing/0001493152-24-044124.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.